LEIDY CARABALLO GALVA to Xenograft Model Antitumor Assays
This is a "connection" page, showing publications LEIDY CARABALLO GALVA has written about Xenograft Model Antitumor Assays.
Connection Strength
0.154
-
Novel low-avidity glypican-3 specific CARTs resist exhaustion and mediate durable antitumor effects against HCC. Hepatology. 2022 08; 76(2):330-344.
Score: 0.154
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.